| P50 | author | Chien-Wen Chen | Q81760841 |
| P2093 | author name string | Hongshuai Li | |
| | Johnny Huard | |
| | Bahar Ahani | |
| | James Cummins | |
| | Mitra Lavasani | |
| | Seth Thompson | |
| | Arvydas Usas | |
| | Minakshi Poddar | |
| P2860 | cites work | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| | A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 |
| | The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells | Q28176663 |
| | Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells | Q28176681 |
| | Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts | Q28269878 |
| | A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo | Q28585539 |
| | Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells | Q28590205 |
| | Satellite cell of skeletal muscle fibers | Q29615148 |
| | The molecular characterization of the fetal stem cell marker AA4. | Q33867815 |
| | Pericyte physiology. | Q34061482 |
| | Platelet-rich plasma in muscle healing | Q34139077 |
| | Oct-4: gatekeeper in the beginnings of mammalian development. | Q34313833 |
| | Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis | Q34363073 |
| | Muscle-derived stem cells: characterization and potential for cell-mediated therapy | Q34488738 |
| | Platelet transfusions: Impact on hemostasis, thrombosis, inflammation and clinical outcomes | Q34708937 |
| | The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β. | Q34778795 |
| | TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells | Q34819515 |
| | Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). | Q34935310 |
| | The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature | Q34995438 |
| | Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation | Q35229856 |
| | Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers. | Q35892125 |
| | Proto-oncogenes in the regulatory circuit for myogenesis | Q36234802 |
| | Development of approaches to improve cell survival in myoblast transfer therapy | Q36290641 |
| | Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration | Q36324366 |
| | Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy | Q36534906 |
| | Stem and progenitor cells in skeletal muscle development, maintenance, and therapy | Q36771273 |
| | Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. | Q36934659 |
| | Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells | Q37035020 |
| | Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. | Q37077963 |
| | Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. | Q37500527 |
| | Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. | Q37698233 |
| | Current concepts for the use of platelet-rich plasma in the foot and ankle | Q37833184 |
| | The impact and management of acquired platelet dysfunction | Q37839756 |
| | Musculoskeletal applications of platelet-rich plasma: fad or future? | Q37846038 |
| | Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach | Q37852876 |
| | Pathogenesis, classification and treatment of inflammatory myopathies | Q37862083 |
| | Sports medicine applications of platelet rich plasma | Q37899244 |
| | Platelet-rich plasma and platelet-rich fibrin in human cell culture | Q39849874 |
| | Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells | Q40243228 |
| | Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells | Q40375826 |
| | Growth factors for bone growth and repair: IGF, TGF beta and BMP. | Q41130799 |
| | Changes in volume and density of platelets in myocardial infarction | Q42822711 |
| | Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications | Q43898390 |
| | Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: a mode of action to enhance bone repair | Q44758162 |
| | Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. | Q45058349 |
| | Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. | Q45501605 |
| | Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. | Q45887966 |
| | The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma. | Q45949821 |
| | Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability | Q46296266 |
| | Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering | Q46308801 |
| | Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure | Q46954706 |
| | Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma | Q47445443 |
| | Platelet-rich plasma: Growth factor enhancement for bone grafts | Q47932652 |
| | Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. | Q48034899 |
| | Platelet-Derived Growth Factor is AngiogenicIn Vivo | Q48606381 |
| | Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. | Q50474597 |
| | Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. | Q50707616 |
| | Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. | Q50790713 |
| | Bone and cartilage formation by skeletal muscle derived cells. | Q50976771 |
| | Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. | Q51018136 |
| | Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. | Q51116042 |
| | In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. | Q51378561 |
| | Large Platelets Circulate in an Activated State in Diabetes Mellitus | Q51609166 |
| | Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. | Q54408978 |
| | Platelet-derived growth factors enhance proliferation of human stromal stem cells | Q57003383 |
| | H-2-dependent binding of xenogeneic beta 2-microglobulin from culture media | Q68140243 |
| | Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro | Q71670550 |
| | Fetal calf serum augmentation during cell separation procedures accounts for the majority of human autologous mixed leukocyte reactivity | Q72840130 |
| | Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction | Q74128191 |
| | Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count | Q74313247 |
| | Osteoprogenitor cells of mature human skeletal muscle tissue: an in vitro study | Q74609163 |
| | Muscle-derived stem cells | Q75230955 |
| | BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells | Q78419904 |
| | Prospective identification of myogenic endothelial cells in human skeletal muscle | Q80982228 |
| | Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction | Q81100792 |
| | Differential myocardial infarct repair with muscle stem cells compared to myoblasts | Q81123128 |
| | The content of bone morphogenetic proteins in platelets varies greatly between different platelet donors | Q81790101 |
| | Two steps forward, one step back | Q82274404 |
| | Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis | Q82437161 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e64923 | |
| P577 | publication date | 2013-06-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness | |
| P478 | volume | 8 | |